Genes

1. Genes, DNA and chromosomes

Genes are segments of genetic material that contribute to biological function through their products. In cellular organisms, genes are made of DNA. Some viruses have RNA genomes and therefore RNA-based genes. A gene need not encode a protein: ribosomal RNA and transfer RNA are functional gene products involved in protein synthesis.

DNA usually forms a double helix with two antiparallel strands. Each nucleotide contains a sugar, phosphate group and nitrogenous base. Adenine pairs with thymine, while guanine pairs with cytosine. The sequence of bases stores biological information. In eukaryotic cells, DNA associates with proteins, especially histones, to form chromatin, which is organised into chromosomes.

The genome is the complete genetic material of an organism or cell. A gene occupies a particular location, called a locus; alternative versions of a gene are called alleles. Homologous chromosomes carry corresponding loci, although their alleles may differ. Genotype refers to genetic constitution, while phenotype refers to observable or measurable characteristics.

Human nuclear DNA is inherited from both parents. Mitochondrial DNA is ordinarily inherited maternally. Plants additionally possess chloroplast genomes. These organellar genomes illustrate why genetic information is not restricted to the nucleus.

• Homozygous: possessing identical alleles at a locus; heterozygous: possessing different alleles.
• Chromosome number does not reliably indicate an organism’s complexity.
• Mature human red blood cells lack nuclei and mitochondria; the usual chromosome count does not apply to them.

2. Gene expression and its regulation

Gene expression is the use of genetic information to produce a functional product. For protein-coding genes, transcription copies DNA information into RNA, and translation uses messenger RNA to assemble a polypeptide at a ribosome. Transfer RNA brings amino acids, while ribosomal RNA forms a major structural and catalytic component of ribosomes.

The genetic code consists of three-base units called codons in messenger RNA. There are 64 codons: 61 specify amino acids and three normally signal termination. AUG generally serves as the start codon and codes for methionine. The code is degenerate, meaning that more than one codon can specify the same amino acid, and nearly universal, with limited exceptions.

In eukaryotes, many genes contain exons interrupted by introns. During RNA processing, introns are removed and exons joined. Alternative splicing can generate different RNA transcripts from one gene, increasing the diversity of protein products. Thus, one gene does not necessarily correspond to one protein.

Regulatory DNA sequences and transcription factors influence where, when and how strongly genes are expressed. Epigenetic mechanisms, including DNA methylation and histone modification, can alter gene activity without changing the underlying DNA sequence. They help explain how cells with broadly similar genomes develop specialised functions.

• The usual information pathway is DNA to RNA to protein; reverse transcription transfers information from RNA to DNA.
• Non-coding DNA is not automatically useless: some regions regulate genes or produce functional RNAs.

3. Inheritance, variation and genetic disorders

Mendel’s experiments with pea plants established principles of inheritance. The law of segregation states that the two alleles at a locus separate during gamete formation. Independent assortment generally applies to genes on different chromosomes or sufficiently far apart on the same chromosome. Closely linked genes tend to be inherited together, although crossing over can separate them.

Dominant and recessive describe relationships between alleles, not their frequency, usefulness or strength. Incomplete dominance produces an intermediate heterozygous phenotype, while codominance allows both alleles to be expressed. The human ABO blood group system illustrates multiple alleles and codominance: the A and B alleles are codominant.

Many characteristics, including height, are polygenic and influenced by environmental conditions. Pleiotropy occurs when one gene affects multiple traits. Mutations are changes in genetic sequence and may be harmful, neutral or beneficial depending on context. Germline mutations can be inherited, whereas somatic mutations are generally not transmitted to offspring.

Sickle-cell disease involves a variant in HBB, which encodes the beta-globin component of haemoglobin. Haemophilia A and B commonly follow X-linked recessive inheritance. Down syndrome, usually caused by an extra chromosome 21, is a chromosomal condition rather than a single-gene disorder. Cancer commonly involves accumulated changes affecting cell growth, DNA repair and cell death.

• Having a disease-associated allele does not always mean disease will develop; penetrance and environmental influences matter.
• Genetic disease and inherited disease are not identical: some genetic changes arise newly in an individual.

4. Genes in biotechnology and medicine

Genome sequencing determines the order of DNA bases; it does not itself change genes. Polymerase chain reaction amplifies selected DNA sequences, enabling applications in diagnostics, research and forensics. DNA profiling compares variable genetic markers to assess identity or biological relationships rather than routinely sequencing an entire genome.

Recombinant DNA technology combines DNA sequences and introduces them into suitable host cells. Engineered microorganisms can manufacture human insulin. Bt cotton contains bacterial genes that enable production of proteins toxic to particular insect pests. Such resistance is target-specific and does not make the crop immune to all pests.

Gene editing makes targeted alterations in genetic material. In CRISPR-Cas9 systems, a guide RNA directs the Cas9 nuclease to a matching DNA region near a suitable recognition motif. Cellular repair after cutting can disrupt a gene or, under appropriate conditions, introduce a planned change. Delivery difficulties, off-target changes and unintended on-target effects remain important concerns.

Gene therapy seeks to treat disease by adding, modifying or regulating genetic material. Ex vivo therapy modifies cells outside the body before returning them; in vivo therapy delivers treatment directly into the body. Pharmacogenomics studies how genetic variation affects responses to medicines, supporting more individualised drug selection and dosing.

• Sequencing reads genetic information; editing changes it; gene therapy is a therapeutic application.
• Not all genetically modified organisms are transgenic: some modifications do not introduce genes from another species.

5. Indian initiatives, regulation and ethical issues

The Human Genome Project, completed in 2003, produced a foundational human reference sequence. References are not identical to every person’s genome, and later projects have improved completeness and representation. India’s genetic diversity makes population-relevant genomic datasets important for interpreting variants and understanding disease risks.

The Department of Biotechnology’s GenomeIndia project sequenced genomes from 10,000 individuals representing diverse Indian populations. Its genome data were dedicated to the nation in January 2025. The Indian Biological Data Centre at Faridabad provides infrastructure for biological data storage and access. Such resources can strengthen research but do not automatically establish the clinical significance of every detected variant.

India’s genetically engineered organism framework includes the 1989 Rules under the Environment (Protection) Act, 1986. The Review Committee on Genetic Manipulation operates under the Department of Biotechnology, while the Genetic Engineering Appraisal Committee functions under the environment ministry. Responsibilities differ according to the activity and regulatory stage.

The ICMR–DBT National Guidelines for Gene Therapy Product Development and Clinical Trials, 2019, address safety and ethical requirements. Key concerns include informed consent, genetic privacy, re-identification risks, discrimination and equitable access. Somatic interventions primarily affect the treated individual; heritable germline changes could affect future generations, raising substantially greater ethical and safety concerns.

• Genetic counselling should explain uncertainty and reproductive options without coercion or stigmatisation.
• Population-level genetic findings should not be treated as rigid biological definitions of caste, ethnicity or social identity.

Genes, Complex Traits and Association Evidence

The supplied metadata describes genes associated with excessive daytime sleepiness, grouped into biological subtypes linked to sleep propensity and sleep fragmentation. This illustrates how different biological mechanisms can contribute to a similar observable trait, or phenotype. A gene is not necessarily a deterministic instruction for one characteristic: complex traits commonly reflect contributions from multiple genes, their regulation and environmental influences. Daytime sleepiness therefore provides a useful example of why a simple “one gene–one trait” model is often inadequate.

An association between a genetic variant and a trait does not, by itself, establish that the variant causes the trait. An associated variant may merely track a nearby causal change; identifying the relevant gene and mechanism requires further evidence. The metadata does not establish the study population, methods or strength of association, so it cannot support clinical predictions or conclusions specific to India. For Indian public health and genomics, the broader lesson is that findings require validation in appropriate populations. Genetic information may help investigate disease susceptibility, but interpretation must also consider clinical history, lifestyle and environmental exposures, alongside consent and privacy.

• Gene versus variant: a gene is a functional DNA unit; variants are sequence differences that may alter function, regulation or neither.
• Polygenic versus Mendelian: many small genetic contributions differ from inheritance primarily driven by a single gene.
• Association versus diagnosis: a research link does not establish causation, justify a screening test or identify a treatment target.

Previous year questions

Practice questions